Oscar Health (NYSE:OSCR) Upgraded at Barclays

Barclays upgraded shares of Oscar Health (NYSE:OSCR) from an underweight rating to an equal weight rating in a research report released on Monday, Marketbeat.com reports. The brokerage currently has $18.00 price target on the stock, up from their previous price target of $13.00.

Other research analysts have also recently issued research reports about the company. UBS Group increased their price objective on Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a research note on Friday, November 7th. Wall Street Zen downgraded Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday, December 6th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a research note on Wednesday, October 8th. Stephens began coverage on shares of Oscar Health in a report on Thursday, December 11th. They set an “equal weight” rating and a $17.00 target price on the stock. Finally, The Goldman Sachs Group began coverage on shares of Oscar Health in a report on Tuesday, October 14th. They issued a “neutral” rating and a $17.00 price target for the company. One analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $16.29.

Oscar Health Stock Performance

OSCR stock opened at $16.51 on Monday. Oscar Health has a twelve month low of $11.20 and a twelve month high of $23.80. The firm has a market cap of $4.37 billion, a price-to-earnings ratio of -14.74 and a beta of 1.90. The business’s fifty day simple moving average is $15.83 and its two-hundred day simple moving average is $16.98. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping the consensus estimate of ($0.55) by $0.02. The company had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The firm’s revenue was up 23.2% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.22) EPS. Analysts predict that Oscar Health will post 0.69 earnings per share for the current year.

Insider Activity

In related news, insider Mario Schlosser sold 38,835 shares of the stock in a transaction that occurred on Wednesday, December 24th. The shares were sold at an average price of $15.00, for a total transaction of $582,525.00. Following the completion of the sale, the insider owned 438,348 shares of the company’s stock, valued at $6,575,220. This represents a 8.14% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Janet Liang sold 7,338 shares of Oscar Health stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $121,737.42. Following the completion of the transaction, the insider directly owned 172,527 shares in the company, valued at $2,862,222.93. This represents a 4.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 383,307 shares of company stock valued at $5,919,555. Corporate insiders own 24.39% of the company’s stock.

Institutional Trading of Oscar Health

Institutional investors have recently made changes to their positions in the business. Envestnet Asset Management Inc. grew its stake in shares of Oscar Health by 200.9% during the second quarter. Envestnet Asset Management Inc. now owns 30,210 shares of the company’s stock worth $648,000 after acquiring an additional 20,171 shares during the last quarter. NewEdge Advisors LLC raised its position in shares of Oscar Health by 89.7% in the 1st quarter. NewEdge Advisors LLC now owns 188,058 shares of the company’s stock valued at $2,465,000 after purchasing an additional 88,946 shares during the last quarter. Matauro LLC acquired a new stake in Oscar Health in the 2nd quarter worth approximately $1,508,000. Kingswood Wealth Advisors LLC purchased a new stake in Oscar Health during the 2nd quarter worth approximately $576,000. Finally, Lane Generational LLC acquired a new position in Oscar Health during the 2nd quarter valued at approximately $4,800,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.